Latest filing published 09 Jun 2026 for Medline Inc., €147k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jessi L. Corcoran holds accounting roles at JBT Marel Corp, as VP, Corporate Controller & CAO, and at Medline Inc., as Principal Accounting Officer. The record has 33 filings, published from February 25, 2019 to June 9, 2026, 32 of them at JBT Marel.
Those 32 filings are all share grants: the record holds no sale. The only open-market purchase is at Medline: EUR 147,016 on June 5, 2026, published with the filing of June 9, 2026. It is also the only filing in the last twelve months.
The yearly calendar stays modest: 1 filing in 2019, 4 in 2020, 4 in 2021, 4 in 2022, 7 in 2023, 6 in 2024, 6 in 2025 and 1 in 2026. Filings appear a median of 4 days after the trade.
The count of trades by Corcoran within 30 days of a colleague at Medline Inc. is 1. None in the same direction. Colleague concerned: BCP 8 Holdings Mozart Manager L.L.C..
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations